臨床外科70巻1号

2015年01月発行

特集 胆道癌外科切除—再発防止のストラテジー 術中戦略

門脈合併切除の手技と意義—R0切除を目指して

著者： 佐野力¹ 有川卓¹ 大澤高陽¹ 岩田力¹ 藤崎宏之¹ 大橋紀文¹ 永田博¹ 宮地正彦¹ 小出龍郎²

所属機関： ¹愛知医科大学消化器外科 ²愛知学院大学高等教育研究所

ページ範囲：P.46 - P.52

【ポイント】
◆門脈合併切除再建は安全に施行可能との報告が多く，R0切除が可能であればためらわずに行う．
◆門脈合併切除再建では，術前・術中のデザインが重要であり，血管鉗子を数回かけ直して確認する．
◆門脈合併切除再建では，助手の役目が重要であり，慌てずゆっくりとチームワークで行う．

参考文献

1）Ebata T, Yokoyama Y, Igami T, et al：Portal vein embolization before extended hepatectomy for biliary cancer：current technique and review of 494 consecutive embolizations. Dig Surg 29：23-29, 2012

2）Miyazaki M, Itoh H, Kaiho T, et al：Portal vein reconstruction at the hepatic hilus using a left renal vein graft. J Am Coll Surg 180：497-498, 1995

3）Sakamoto Y, Yamamoto J, Saiura A, et al：Reconstruction of hepatic or portal veins by use of newly customized great saphenous vein grafts. Langenbecks Arch Surg 389：110-113, 2004

4）Suzuki T, Yoshidome H, Kimura F, et al：Renal function is well maintained after use of left renal vein graft for vascular reconstruction in hepatobiliary-pancreatic surgery. J Am Coll Surg 202：87-92, 2006

5）Kito Y, Nagino M, Kamiya J, et al：Asymptomatic portal vein obstruction after hepatobiliary resection：early detection by Doppler ultrasonography. Hepatogastroenterology 48：550-552, 2001

6）梶谷　鐶，久野敬二郎，菱田泰治，他：肝門部胆管癌の手術治療．手術20：997-1002，1966

7）Nimura Y, Hayakawa N, Kamiya J, et al：Combined portal vein and liver resection for carcinoma of the biliary tract. Br J Surg 78：727-731, 1991

8）Igami T, Nishio H, Ebata T, et al：Surgical treatment of hilar cholangiocarcinoma in the “new era”：the Nagoya University experience. J Hepatobiliary Pancreatic Sci 17：449-454, 2010

9）Hirano S, Kondo S, Tanaka E, et al：Outcome of surgical treatment of hilar cholangiocarcinoma：a special reference to postoperative morbidity and mortality. J Hepatobiliary Pancreatic Sci 17：455-462, 2010

10）Unno M, Katayose Y, Rikiyama T, et al：Major hepatectomy for perihilar cholangiocarcinoma. J Hepatobiliary Pancreatic Sci 17：463-469, 2010

11）Miyazaki M, Kimura F, Shimizu H, et al：One hundred seven consecutive surgical resections for hilar cholangiocarcinoma of Bismuth types Ⅱ, Ⅲ, Ⅳ between 2001 and 2008. J Hepatobiliary Pancreatic Sci 17：470-475, 2010

12）Lee SG, Song GW, Hwang S, et al：Surgical treatment of hilar cholangiocarcinoma in the new era：the Asan experience. J Hepatobiliary Pancreatic Sci 17：476-489, 2010

13）Rocha FG, Matsuo K, Blumgart LH, et al：Hilar cholangiocarcinoma：the Memorial Sloan-Kettering Cancer Center experience. J Hepatobiliary Pancreatic Sci 17：490-496, 2010

14）Young AL, Prasad RK, Toogood GJ, et al：Surgical treatment of hilar cholangiocarcinoma in a new era：comparison among leading Eastern and Western centers, Leeds. J Hepatobiliary Pancreatic Sci 17：497-504, 2010

15）Hemming AW, Mekeel K, Khanna A, et al：Portal vein resection in management of hilar cholangiocarcinoma. J Am Coll Surg 212：604-613, 2011

16）de Jong MC1, Marques H, Clary BM, et al：The impact of portal vein resection on outcomes for hilar cholangiocarcinoma：a multi-institutional analysis of 305 cases. Cancer 118：4737-4747, 2012

17）Neuhaus P, Thelen A, Jonas S, et al：Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma. Ann Surg Oncol 19：1602-1608, 2012

18）Tamoto E, Hirano S, Tsuchikawa T, et al：Portal vein resection using the no-touch technique with a hepatectomy for hilar cholangiocarcinoma. HPB（Oxford）16：56-61, 2014

19）Nishio H, Ebata T, Yokoyama Y, et al：Gallbladder cancer involving the extrahepatic bile duct is worthy of resection. Ann Surg 253：953-960, 2011